Showing results (1-10 of 386) with videos related to
Sort By:
Pageof 39
Hematology. American Society of Hematology. Education Program|December 10, 2017
What are the current treatment approaches for patients with polycythemia vera and essential thrombocythemia?Alessandro M Vannucchi, Paola GuglielmelliBlood Reviews|June 18, 2020
Current management strategies for polycythemia vera and essential thrombocythemiaPaola Guglielmelli, Alessandro M VannucchiSeminars in Thrombosis and Hemostasis|May 2, 2013
JAK2 mutation-related disease and thrombosisAlessandro M Vannucchi, Paola GuglielmelliF1000 Medicine Reports|October 16, 2010
Recent advances in diagnosis and treatment of chronic myeloproliferative neoplasmsPaola Guglielmelli, Alessandro M VannucchiCurrent Opinion in Oncology|September 1, 2010
Advances in understanding and management of polycythemia veraAlessandro M Vannucchi, Paola GuglielmelliExpert Opinion on Therapeutic Targets|May 6, 2020
Polycythemia vera: the current status of preclinical models and therapeutic targetsNiccolò Bartalucci, Paola Guglielmelli, Alessandro M VannucchiTherapeutic Advances in Hematology|April 5, 2013
JAK2 Allele Burden in the Myeloproliferative Neoplasms: Effects on Phenotype, Prognosis and Change with TreatmentAlessandro M Vannucchi, Lisa Pieri, Paola GuglielmelliExpert Review of Hematology|February 21, 2020
Stem cell transplant for the treatment of myelofibrosisLara Mannelli, Paola Guglielmelli, Alessandro M VannucchiCA: a Cancer Journal for Clinicians|April 17, 2009
Advances in understanding and management of myeloproliferative neoplasmsAlessandro M Vannucchi, Paola Guglielmelli, Ayalew TefferiClinical Lymphoma, Myeloma & Leukemia|December 3, 2013
Rationale for targeting the PI3K/Akt/mTOR pathway in myeloproliferative neoplasmsNiccolò Bartalucci, Paola Guglielmelli, Alessandro M VannucchiPageof 39